Atlas Trials

Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib

Clinical trial NCT02268734 · COMPLETED

Trial details

NCT number
NCT02268734
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Sporadic Medullary Thyroid Cancer
Start date
2014-04-01
Primary completion
2017-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.